Literature DB >> 12587112

Properties of rapidly dissolving eutectic mixtures of poly(ethylene glycol) and fenofibrate: the eutectic microstructure.

Devalina Law1, Weili Wang, Eric A Schmitt, Yihong Qiu, Steven L Krill, James J Fort.   

Abstract

Poly(ethylene glycol) or PEG is an ideal inactive component for preparing simple binary eutectic mixtures because of its low entropy of fusion ( approximately 0.0076 J/mol-K), lower melting point (approximately 62 degrees C) compared to most pharmaceuticals, miscibility with drugs at elevated temperatures, and its covalent crystalline lattice. Implication of these physicochemical properties on eutectic crystallization and size reduction of the drug is discussed. Enhancement of the dissolution rate of a poorly soluble compound through the formation of PEG-drug eutectics was investigated using fenofibrate. Solid dispersions of PEG-fenofibrate when characterized, revealed that PEG and fenofibrate form a simple eutectic mixture containing 20-25%(w/w) fenofibrate at the eutectic point. Eutectic crystallization led to the formation of an irregular microstructure in which fenofibrate crystals were found to be less than 10 microm in size. Dissolution rate improvement of fenofibrate correlated with the phase diagram, and the amount of fenofibrate released from the dispersions that contained fenofibrate as a eutectic mixture was at least 10-fold higher compared to untreated fenofibrate. On aging, the dissolution rate of the dispersion containing 15%(w/w) fenofibrate in PEG remained unaltered. The results indicate that PEG-drug eutectic formation is a valuable option for particle size reduction and subsequent dissolution rate improvement. Copyright 2003 Wiley-Liss, Inc. and the American Pharmaceutical Association

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12587112     DOI: 10.1002/jps.10324

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  9 in total

1.  Evaluation of topical hesperetin matrix film for back-of-the-eye delivery.

Authors:  Goutham R Adelli; Tushar Hingorani; Nagendra Punyamurthula; Sai Prachetan Balguri; Soumyajit Majumdar
Journal:  Eur J Pharm Biopharm       Date:  2015-02-26       Impact factor: 5.571

2.  Preparation and in vivo evaluation of SMEDDS (self-microemulsifying drug delivery system) containing fenofibrate.

Authors:  Ashok R Patel; Pradeep R Vavia
Journal:  AAPS J       Date:  2007-10-26       Impact factor: 4.009

Review 3.  Emerging Multi-Drug Eutectics: Opportunities and Challenges.

Authors:  Jamshed Haneef; Shakir Ali; Renu Chadha
Journal:  AAPS PharmSciTech       Date:  2021-02-07       Impact factor: 3.246

4.  Preparation and drug loading of poly(ethylene glycol)-block-poly(epsilon-caprolactone) micelles through the evaporation of a cosolvent azeotrope.

Authors:  Karen K Jette; Devalina Law; Eric A Schmitt; Glen S Kwon
Journal:  Pharm Res       Date:  2004-07       Impact factor: 4.200

5.  Enhanced Dissolution of Naproxen by Combining Cocrystallization and Eutectic Formation.

Authors:  Hakyeong Kim; Soeun Jang; Il Won Kim
Journal:  Pharmaceutics       Date:  2021-04-25       Impact factor: 6.321

6.  Investigation of the in vitro performance difference of drug-Soluplus® and drug-PEG 6000 dispersions when prepared using spray drying or lyophilization.

Authors:  Mohammad A Altamimi; Steven H Neau
Journal:  Saudi Pharm J       Date:  2016-09-30       Impact factor: 4.330

7.  Formulation development and dissolution rate enhancement of efavirenz by solid dispersion systems.

Authors:  P T Koh; J N Chuah; Meghna Talekar; A Gorajana; S Garg
Journal:  Indian J Pharm Sci       Date:  2013-05       Impact factor: 0.975

8.  Feasibility of Using Gluconolactone, Trehalose and Hydroxy-Propyl Gamma Cyclodextrin to Enhance Bendroflumethiazide Dissolution Using Lyophilisation and Physical Mixing Techniques.

Authors:  Ashraf Saleh; Kenneth McGarry; Cheng Shu Chaw; Amal Ali Elkordy
Journal:  Pharmaceutics       Date:  2018-02-01       Impact factor: 6.321

9.  Eutectic Formation of Naproxen with Some Dicarboxylic Acids.

Authors:  Dahye Kim; Soeun Jang; Il Won Kim
Journal:  Pharmaceutics       Date:  2021-12-04       Impact factor: 6.321

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.